Form 4 holding
Chief Financial Officer
BIOCRYST PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 268,700
- Estimated value
- $1,862,091
- Report date
- 17 Dec 2025
- Price
- $6.93
- Ownership
- Direct
Babar Ghias - Chief Financial Officer at BIOCRYST PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- BCRX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Babar Ghias since 28 Sep 2025
Reported holdings for Babar Ghias in BIOCRYST PHARMACEUTICALS INC
Form 4 holding
Chief Financial Officer
BIOCRYST PHARMACEUTICALS INC
- Security class
- Emp. Stock Option (Right to Buy)
- Shares / value
- 355,050
- Estimated value
- Report date
- 17 Dec 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Babar Ghias in BIOCRYST PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.